(Q39922483)

15 September 2017

title

Quantitative assessment of minimal residual disease (MRD) in canine lymphoma by using real-time polymerase chain reaction (English)

1 reference

15 September 2017

Jumpei Yamazaki

1

1 reference

15 September 2017

Kenji Baba

2

1 reference

15 September 2017

Yuko Goto-Koshino

3

1 reference

15 September 2017

Asuka Setoguchi-Mukai

4

1 reference

15 September 2017

Yasuhito Fujino

5

1 reference

15 September 2017

Koichi Ohno

6

1 reference

15 September 2017

Hajime Tsujimoto

7

1 reference

15 September 2017

publication date

19 September 2008

1 reference

Veterinary Immunology and Immunopathology

15 September 2017

published in

1 reference

15 September 2017

volume

126

1 reference

15 September 2017

issue

3-4

1 reference

15 September 2017

page(s)

321-331

1 reference

Quantitative PCR detection of t(14;18) bcl-2/JH fusion sequences in follicular lymphoma patients: comparison of peripheral blood and bone marrow aspirate samples

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Significance of minimal residual disease in lymphoid malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Evolution of a B-cell lymphoma to multiple myeloma after chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Cytohistological and immunological classification of canine malignant lymphomas: comparison with human non-Hodgkin's lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

A combination chemotherapy protocol with dose intensification and autologous bone marrow transplant (VELCAP-HDC) for canine lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Monitoring disease in lymphoma and CLL patients using molecular techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Detection of neoplastic lymphocytes in peripheral blood of dogs with lymphoma by polymerase chain reaction for antigen receptor gene rearrangement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Monitoring of minimal residual disease in acute myeloid leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Utility of polymerase chain reaction for analysis of antigen receptor rearrangement in staging and predicting prognosis in dogs with lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Use of multigeneration-family molecular dog leukocyte antigen typing to select a hematopoietic cell transplant donor for a dog with T-cell lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Does L-asparaginase influence efficacy or toxicity when added to a standard CHOP protocol for dogs with lymphoma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Lack of correlation between numbers of circulating t(14;18)-positive cells and response to first-line treatment in follicular lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Graft-versus-lymphoma effect of donor leucocyte infusion shown by real-time quantitative PCR analysis of t(14;18)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Association of clinical status of follicular lymphoma patients after autologous stem cell transplant and quantitative assessment of lymphoma in blood and bone marrow as measured by SYBR Green I polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Monitoring gastric lymphoma in peripheral blood by quantitative IgH allele-specific oligonucleotide real-time PCR and API2-MALT1 PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Novel real-time PCR assay using a universal molecular marker for diagnosis of hematologic cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

The multiparametric scanning system for evaluation of minimal residual disease in hematological malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Rapid detection of clonal T-cell receptor-beta gene rearrangements in T-Cell lymphomas using the LightCycler-polymerase chain reaction with DNA melting curve analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

Quantitative assessment of contaminating tumor cells in autologous peripheral blood stem cells of B-cell non-Hodgkin lymphomas using immunoglobulin heavy chain gene allele-specific oligonucleotide real-time quantitative-polymerase chain reaction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.09.004

10.1016/J.VETIMM.2008.09.004

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference